External Pacemakers Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.88 Billion |
| Market Size (2030) | USD 2.27 Billion |
| CAGR (2025 - 2030) | 3.84% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
External Pacemakers Market Analysis
The External Pacemakers Market size is estimated at USD 1.88 billion in 2025, and is expected to reach USD 2.27 billion by 2030, at a CAGR of 3.84% during the forecast period (2025-2030).
The external pacemakers market was significantly impacted during the COVID-19 pandemic owing to a decrease in elective procedures and non-urgent medical device implantations, including external pacemakers. Moreover, various disruptions, including supply chain issues and manufacturing challenges, significantly impacted the manufacturing and distribution of external pacemakers, which has also affected the delivery of timely solutions to patients. According to the Journal of Arrhythmia from NIH published in February 2022, COVID-19 significantly impacted the temporary pacemaker usage rates during the first wave of COVID-19. Still, later, the implication of external pacemaker devices increased remarkably owing to the surging trend of remote monitoring.
According to Sociedad Española de Cardiología (Spanish Society of Cardiology) data of August 2023, the remote monitoring of cardiac implantable electronic devices increased exponentially post-lockdown period and shifted a trend of cardiac monitoring. Thus, the pandemic has had a mixed impact on the external pacemaker market, and the industry is likely to have lucrative growth opportunities in the coming years due to the rising disease burden and high penetration of telemedicine.
The increasing burden of cardiovascular conditions coupled with several risks associated with cardiovascular diseases (CVDs) is driving the global external pacemakers market. Some of the most important risk factors contributing to the higher burden of CVDs include a sedentary lifestyle, physical inactivity, and a surge in an aging population. According to WHO’s data of September 2023, cardiovascular diseases are the leading cause of death across the world, and an estimated 17.9 million people die from it every year. Moreover, more than four out of five cardiovascular disease deaths are owing to stroke and heart failure, which mainly occur from arrhythmia and irregular heart rate. This expanding patient pool, along with the higher need for precise cardiac care, has created a robust demand for various cardiac devices, including external pacemakers, thereby fostering the market opportunity for manufacturers.
Moreover, rising demand for temporary pacemakers owing to several benefits like non-invasive pacing, convenient operation, and leveraging clinical significance has created a high demand across end-users like hospitals, clinician’s offices, and ambulatory surgery centers. For instance, various kinds of conduction abnormalities, including ventricular tachycardia and bradycardia, can be typically managed with an external pacing system until tailored treatment is developed. In addition, the external pacing system has also been found useful in reversing conditions like myocardial infarction and drug-induced electrical disturbances. For instance, according to the National Center of Biotechnology Information’s data from September 2022, external pacing is the fastest and most convenient method to manage emergencies and rhythm disorders like tachycardia and bradycardia. Thus, the ability of external pacing systems to maintain adequate cardiac output in emergencies has facilitated their demand across end-users like hospitals, ambulatory surgical centers, and clinics.
In addition, the increasing geriatric population globally and the presence of various public and private organizations promoting awareness regarding CVDs and arrhythmia are further supporting the global market. For instance, the World Heart Federation is a leading non-governmental organization (NGO) engaged in creating awareness regarding CVDs around the globe in partnership with the WHO.
Also, the surging elderly population, especially those over age 65, are more susceptible to heart rhythm-related disorders, and they often need an external pacing system to maintain a regular heart rate. According to Statistics Canada, in July 2022, over 7.33 million Canadians were aged more than 65 years and older, and the country’s elderly population is projected to grow by 68% over the next 20 years. There is a close relationship between the elderly population and the risk of developing CVD. Hence, the growing elderly population is projected to create a high demand for external pacing systems in the near future. For instance, according to the European Heart Journal published in December 2022, temporary pacemakers can be utilized in elderly patients to achieve atrioventricular synchronous pacing.
Furthermore, technological advancements have made these pacemakers more efficient and user-friendly, thereby bolstering their adoption. Moreover, the evolving disease landscape and high demand for advanced external pacing systems have facilitated manufacturers to develop advanced and precise pacing solutions. For instance, in July 2023, BIOTRONIK received U.S. FDA approval for its next-generation family of pacemakers. This pacemaker family of the company also comprises Amvia Edge, the industry’s smallest single-chamber MR (magnetic resonance) conditional pacemaker for best patient-centric outcomes. This approval marked a significant step in cardiac pacing platforms.
However, factors such as the higher cost of external pacing devices and stringent regulatory frameworks are anticipated to hamper industry growth over the forecast period.
External Pacemakers Market Trends
Dual Chamber Segment is Expected to Hold a Major Market Share
The dual chamber external pacemakers segment held the largest revenue share in the base year and is projected to maintain its dominance over the forecast period. The largest revenue share of the segment is driven by factors like the high burden of cardiovascular diseases and growing demand for dual-chamber pacemakers owing to various benefits associated with them, like interactive use interface, long battery life, and suitability of dual-chamber pacemakers in emergencies. Moreover, the high preference for dual-chamber pacemakers by healthcare professionals owing to their ability to pace cardiac output both in the elderly as well as young adults is further supporting segment expansion. Dual chamber devices provide more synchronized and sophisticated pacing, which makes them suitable for a wide range of heart conditions.
Moreover, growing hospitalizations from cardiovascular conditions and an increasing need for an external pacemaker system for balancing cardiac pacing are other factors supporting segment growth. For instance, according to Centers for Disease Control and Prevention (CDC) data from October 2022, more than 454,000 hospitalizations with atrial fibrillation happen every year in the United States, and the condition causes around 158,000 deaths every year. Thus, the high burden of AFib facilitates the demand for dual-chamber pacemakers to mimic the natural cardiac rhythm.
Furthermore, the presence of a robust product portfolio, high preference for dual chamber pacemakers, convenient operation, and higher application of these pacemakers in continuous patient monitoring are further accelerating their adoption. For instance, the Dual Chamber Temporary External Pacemaker of Medtronic comes with an enhanced user interface and is very suitable for continuous patient monitoring. In addition, dual-chamber external pacemaker devices have transformed the cardiology space as they are safer options for pacing. For instance, in October 2022, Dr. Nilsson of Piedmont Hospital implanted one of the first wireless dual chamber pacemakers into a patient. The implanted pacemaker is much safer than conventional cardiac devices.
Thus, factors like increasing demand for dual chamber systems, high preference by healthcare professionals, and technological advancements are driving segment growth forward.
North America is Expected to Dominate the External Pacemakers Market
North America is expected to dominate the market owing to factors such as increasing prevalence of heart conditions, rising geriatric population, and strong presence of leading market participants. According to the CDC data of May 2023, cardiovascular diseases are the leading cause of death for both men and women in the United States, and one person dies every 33 seconds in the United States due to a heart condition. Thus, such a high burden of target diseases is anticipated to offer lucrative growth opportunities for the regional market. Also, a supportive regulatory framework and accelerated product approvals are further supporting industry uptake. For instance, in May 2023, Medtronic plc announced a U.S. FDA approval of Micra VR2 and Micra AV2 pacemakers. These are the next-generation pacemakers with longer battery life and higher pacing capabilities.
Moreover, a favorable reimbursement framework and policies that support heart treatments are further contributing to the regional market growth. For instance, in the United States, the reimbursement for temporary pacemakers is governed by CMS, and the authority provides coverage to all procedures performed at healthcare facilities that particular CPT codes have registered. In addition, in Canada, the reimbursement for cardiac devices varies from province to province. Thus, favorable reimbursement policies in the region support the demand for external pacemakers.
Therefore, owing to factors like the high burden of CVDs, the rising geriatric population in the region, and the favorable reimbursement framework are anticipated to drive regional market growth in the study period.
External Pacemakers Industry Overview
The external pacemakers market is moderately consolidated in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Medtronic, OSYPKA MEDICAL, OSCOR Inc, Fluke (Fortive), Avery Biomedical Devices, Inc, BIOTRONIK, Lepu Medical Technology(Beijing) Co., Ltd., Netech Corporation, FIAB SpA, ATACOR MEDICAL, INC., Cor-Medical among others.
External Pacemakers Market Leaders
-
Medtronic
-
OSYPKA MEDICAL
-
OSCOR Inc
-
Avery Biomedical Devices, Inc
-
BIOTRONIK
- *Disclaimer: Major Players sorted in no particular order
External Pacemakers Market News
- July 2023: Abbott received U.S. FDA approval for the AVEIR dual chamber (DR) pacemaker device. This system is the world’s first pacing system that treats people with slow or abnormal heart rhythms. The newly approved device is a minimally invasive approach to pace abnormal heart rhythms.
- October 2022: Ceryx Medical, a Welsh MedTech company, partnered with Osypka to develop a cardiac pacing device to treat cardiac conditions. This partnership aimed to develop a device that was expected to take pace to the next level with real-time modulation.
External Pacemakers Industry Segmentation
As per the scope of the report, an external pacemaker or temporary pacemaker is an electrode-based device that is used to regulate heart rhythm and a normal heart rate. The external pacemakers market is segmented by product (single chamber and dual chamber), application (bradycardia, acute myocardial infarction, and other applications), end-user (hospitals, ambulatory surgical centers, and other end-users), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Product | Single Chamber | ||
| Dual Chamber | |||
| By Application | Bradycardia | ||
| Acute Myocardial Infarction | |||
| Other Applications | |||
| By End-Users | Hospitals | ||
| Ambulatory Surgical Centers | |||
| Other End-Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Single Chamber |
| Dual Chamber |
| Bradycardia |
| Acute Myocardial Infarction |
| Other Applications |
| Hospitals |
| Ambulatory Surgical Centers |
| Other End-Users |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
External Pacemakers Market Research FAQs
How big is the External Pacemakers Market?
The External Pacemakers Market size is expected to reach USD 1.88 billion in 2025 and grow at a CAGR of 3.84% to reach USD 2.27 billion by 2030.
What is the current External Pacemakers Market size?
In 2025, the External Pacemakers Market size is expected to reach USD 1.88 billion.
Who are the key players in External Pacemakers Market?
Medtronic, OSYPKA MEDICAL, OSCOR Inc, Avery Biomedical Devices, Inc and BIOTRONIK are the major companies operating in the External Pacemakers Market.
Which is the fastest growing region in External Pacemakers Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in External Pacemakers Market?
In 2025, the North America accounts for the largest market share in External Pacemakers Market.
What years does this External Pacemakers Market cover, and what was the market size in 2024?
In 2024, the External Pacemakers Market size was estimated at USD 1.81 billion. The report covers the External Pacemakers Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the External Pacemakers Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
External Pacemakers Industry Report
Statistics for the 2025 External Pacemakers market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. External Pacemakers analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
